Petros Pharmaceuticals, Inc. (PTPI) › Cost of RevenuePetros Pharmaceuticals, Inc. (PTPI) — Cost of RevenueAnnual figures by period end, from SEC filings.2020-12-31: $4.05M2021-12-31: $1.60M2022-12-31: $2.29M2023-12-31: $1.63M2024-12-31: $1.21M$1.21M2020-12-31Cost of Revenue (USD)2024-12-31Period endedCost of RevenueChange YoYSource filing2024-12-31$1.21M-25.7%2025-03-31From 2024-01-012023-12-31$1.63M-28.7%2025-03-31From 2023-01-012022-12-31$2.29M+43.1%2024-04-01From 2022-01-012021-12-31$1.60M-60.5%2023-03-31From 2021-01-012020-12-31$4.05M—2022-03-31From 2020-01-01Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)